Andrew E Hendifar Selected Research

Fatigue

1/2021	Symptom Management in Pancreatic Cancer.
1/2020	Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew E Hendifar Research Topics

Disease

27	Neoplasms (Cancer) 03/2024 - 02/2008
14	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 01/2014
13	Adenocarcinoma 04/2024 - 03/2017
7	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 11/2017
5	Neoplasm Metastasis (Metastasis) 11/2022 - 04/2017
4	Disease Progression 05/2023 - 01/2017
3	Cachexia 12/2021 - 01/2014
3	Colonic Neoplasms (Colon Cancer) 10/2021 - 02/2008
2	Carcinogenesis 03/2024 - 11/2022
2	Primitive Neuroectodermal Tumors (PNET) 12/2022 - 01/2018
2	Diarrhea 03/2021 - 01/2018
2	Fatigue 01/2021 - 01/2020
2	Pain (Aches) 01/2021 - 07/2019
2	Sarcoma (Soft Tissue Sarcoma) 10/2014 - 09/2012
1	COVID-19 10/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022
1	Neuroendocrine Carcinoma 08/2021
1	Anemia 08/2021
1	Thrombocytopenia (Thrombopenia) 08/2021
1	Flushing 03/2021
1	Abdominal Pain (Pain, Abdominal) 03/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Hyponatremia 01/2020
1	Spasm (Spasms) 01/2020
1	Turcot syndrome 01/2019
1	Adenoma (Adenomas) 01/2019
1	Obesity 02/2018
1	Cardiotoxicity 01/2018
1	Nausea 01/2018
1	Stomatitis 01/2018
1	Inflammation (Inflammations) 03/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2017
1	Margins of Excision 03/2016

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2018
6	Gemcitabine FDA Link 05/2023 - 04/2017
6	Hyaluronic Acid (Hyaluronan)IBA 11/2022 - 01/2018
4	130-nm albumin-bound paclitaxelIBA 05/2023 - 01/2018
4	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 02/2009
3	PEGPH20IBA 11/2022 - 01/2018
2	Glutamine (L-Glutamine)FDA Link 03/2024 - 05/2023
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2022 - 01/2018
2	TOR Serine-Threonine KinasesIBA 12/2022 - 01/2018
2	Radioisotopes (Radionuclides)IBA 01/2022 - 01/2018
2	Peptide Receptors (Peptide Receptor)IBA 01/2022 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2017
2	Everolimus FDA Link 01/2018 - 01/2017
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018 - 03/2017
1	Keratin-17 (Keratin 17)IBA 04/2024
1	Essential Amino AcidsIBA 03/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2023
1	VaccinesIBA 10/2023
1	AntibodiesIBA 10/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	Capecitabine (Xeloda)FDA Link 01/2023
1	sapanisertibIBA 12/2022
1	thiamine triphosphorate (TTP)IBA 11/2022
1	Programmed Cell Death 1 ReceptorIBA 11/2022
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 11/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2022
1	erdafitinibIBA 10/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022
1	Peptides (Polypeptides)IBA 12/2021
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	Phosphocreatine (Neoton)IBA 10/2021
1	Leflunomide (Arava)FDA LinkGeneric 10/2021
1	Dihydroorotate DehydrogenaseIBA 10/2021
1	creatine transporterIBA 10/2021
1	CreatineIBA 10/2021
1	delta proteinIBA 08/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2021
1	rovalpituzumab tesirineIBA 08/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 03/2021
1	lutetium Lu 177 dotatateIBA 03/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Leucovorin (Folinic Acid)FDA Link 01/2021
1	Phosphorus-32IBA 01/2020
1	pembrolizumabIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	EnzymesIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2018
1	dactolisibIBA 01/2018
1	gallium Ga 68 dotatateIBA 11/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2017
1	AZD 6244IBA 04/2017
1	MK 2206IBA 04/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2017
1	Cell-Free Nucleic AcidsIBA 10/2015

Therapy/Procedure

24	Therapeutics 03/2024 - 02/2008
8	Drug Therapy (Chemotherapy) 05/2024 - 10/2014
2	Radiotherapy 05/2024 - 07/2019
2	Immunotherapy 04/2023 - 01/2018
2	Precision Medicine 10/2018 - 10/2015
2	Adjuvant Chemotherapy 02/2009 - 02/2008
1	Operative Surgical Procedures 02/2024
1	Enteral Nutrition (Feeding, Tube) 12/2021
1	Neoadjuvant Therapy 01/2020
1	Brachytherapy 01/2020